These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9703859)

  • 1. Phase II study of the modified regimen of etoposide, leucovorin and 5-fluorouracil for patients with advanced gastric cancer.
    Chiou TJ; Tung SL; Hsieh RK; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
    Jpn J Clin Oncol; 1998 May; 28(5):318-22. PubMed ID: 9703859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
    Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
    Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced gastric cancer with a modified regimen of etoposide/leucovorin/5-fluorouracil.
    Chiou TJ; Kung SP; Hsieh RK; Fan S; Tzeng CH; Wei CH; Chen PM
    Cancer Invest; 1996; 14(3):197-201. PubMed ID: 8630679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
    Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
    Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel and leucovorin-modulated infusional 5-fluorouracil combination chemotherapy for metastatic gastric cancer.
    Cho BC; Kim JH; Kim CB; Sohn JH; Choi HJ; Lee YC; Ahn JB
    Oncol Rep; 2006 Mar; 15(3):621-7. PubMed ID: 16465422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II trial of etoposide, leucovorin and 5-fluorouracil (ELF) in patients with advanced gastric cancer.
    Au E; Koo WH; Tan EH; Ang PT
    J Chemother; 1996 Aug; 8(4):300-3. PubMed ID: 8873837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etoposide, leucovorin and 5-fluorouracil in advanced gastric cancer: a phase II study.
    Van Cutsem E; Filez L; Dewyspelaere J; Penninckx F; Janssens J
    Anticancer Res; 1995; 15(3):1079-80. PubMed ID: 7645929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I-II study of 5-fluorouracil, leucovorin, doxorubicin, methotrexate, and long-term oral etoposide (FLAME) in unresectable or metastatic gastric cancer.
    Bjarnason GA; Cripps C; Goel R; Fine S; Oza AM; Skillings JR; Kerr I; Germond CJ; Moore MJ; Maroun JA; Franssen E; Dulude H
    Am J Clin Oncol; 1998 Dec; 21(6):537-42. PubMed ID: 9856651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy comprising 5-fluorouracil, leucovorin, etoposide, and cis-diamminedichloroplatinum for the treatment of advanced gastric cancer.
    Mochizuki F; Fujii M; Kasakura Y; Yamagata M; Kochi M; Wakabayashi K; Kanamori N; Takayama T
    J Cancer Res Clin Oncol; 2002 Sep; 128(9):493-6. PubMed ID: 12242513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: a phase II study.
    Adamo V; Scimone A; Maisano R; Altavilla G; Ferraro G; Laudani A; Pergolizzi S; Zanghì M
    J Chemother; 1999 Feb; 11(1):74-7. PubMed ID: 10078785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen: two parallel randomized phase II studies.
    Barone C; Corsi DC; Pozzo C; Cassano A; Fontana T; Noviello MR; Landriscina M; Colloca G; Astone A
    Cancer; 1998 Apr; 82(8):1460-7. PubMed ID: 9554521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancer.
    Rosati G; Tucci A; Rinaldi A; Colarusso D; Pizza C; Reggiardo G; Manzione L
    Oncology; 2004; 66(5):371-8. PubMed ID: 15331924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II trial of 5-fluorouracil, leucovorin and mitomycin C in patients with advanced gastric cancer.
    Kim SR; Yuh YJ; Sohn BS; Yang SH
    Tumori; 2011; 97(6):698-703. PubMed ID: 22322834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with locoregional and metastatic gastric adenocarcinoma.
    Partyka S; Dumas P; Ajani J
    Cancer; 1999 Jun; 85(11):2336-9. PubMed ID: 10357402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oxaliplatin combined with ELF regimen in the treatment of patients with advanced gastric cancer].
    Lou F; Zhu YH; Pan HM
    Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):75-8. PubMed ID: 19538878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of advanced gastric cancer with etoposide, folinic acid, and fluorouracil in the clinical setting: efficacy of therapy and value of serum tumor markers.
    Schulze-Bergkamen H; Zuna I; Teufel A; Stremmel W; Rudi J
    Med Oncol; 2002; 19(1):43-53. PubMed ID: 12025890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy with P-ELF (cisplatin, etoposide, leucovorin, 5-fluorouracil) followed by radical resection in patients with initially unresectable gastric adenocarcinoma: a phase II study.
    Gallardo-Rincón D; Oñate-Ocaña LF; Calderillo-Ruiz G
    Ann Surg Oncol; 2000; 7(1):45-50. PubMed ID: 10674448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer--a phase II study in elderly patients or patients with cardiac risk.
    Wilke H; Preusser P; Fink U; Achterrath W; Lenaz L; Stahl M; Schober C; Link H; Meyer HJ; Lucke B
    Invest New Drugs; 1990 Feb; 8(1):65-70. PubMed ID: 2345071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer.
    Chen LT; Liu TW; Wu CW; Chung TR; Shiah HS; Jan CM; Liu JM; Whang-Peng J; Chang JY
    Oncology; 2002; 63(3):239-47. PubMed ID: 12381903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).
    Hudes GR; Lipsitz S; Grem J; Morrisey M; Weiner L; Kugler JW; Benson A
    Cancer; 1999 Jan; 85(2):290-4. PubMed ID: 10023694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.